COVID-19 boosters authorized by FDA: What UI Health Care employees can expect next

On Friday, Sept. 17, the Food and Drug Administration (FDA) authorized the Pfizer-BioNTech COVID-19 vaccine to be given as a booster under emergency use for eligible individuals. 

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) is expected to meet this week to review and provide recommendations for COVID-19 boosters. This group must make their recommendations before COVID-19 vaccine boosters can be administered. The Iowa Department of Public Health must also approve before boosters can begin within Iowa.

What you can expect next

If the ACIP provides recommendations for the Pfizer-BioNTech COVID-19 vaccine booster, here’s what will happen for UI Health Care employees: 

  • You’ll see additional details about the recommendations that ACIP has shared in Noon News and on The Loop.
  • Employees eligible for boosters will receive an email from the University Employee Health Clinic (UEHC) giving instructions for Ready Set survey completion and self-scheduling their booster appointments. Be sure to check your email for this message.
  • Individuals will be eligible for vaccination based on the timing of their second dose. The ACIP will make the determination on how much time must have passed after your second dose before you will be eligible for your booster.
  • Vaccination notification messages will be sent in batches, which means you may be eligible to receive your booster vaccination but not immediately receive your notice to schedule. Please do not call the University Employee Health Clinic to ask when you may become eligible.
  • The booster process will take time. This is because some 15,000 employees may become eligible within a narrow window of time. University Employee Health Clinic will work diligently to administer the boosters based on ACIP’s criteria. 
  • At this time, the only vaccine authorized for boosters is the Pfizer-BioNTech COVID-19 vaccine.